期刊文献+

阿托伐他汀钙对顽固性高血压降压疗效影响的临床分析 被引量:4

Clinical analysis of influence of depresser effect to unprogressive high blood pressure in patients with Atorvastatin calcium tablets
下载PDF
导出
摘要 目的分析探讨阿托伐他汀钙在治疗中老年顽固性高血压中对降压疗效的影响情况。方法选择86例在笔者所在医院住院或门诊已明确为顽固性高血压病的患者,在进行常规降压治疗(足量的3联或3联以上降压药联合应用)3~6个月均未能达到降压目标值140/90 mm Hg时,加用阿托伐他汀钙20 mg,1次/d,随访3~6个月,平均4个月,观察患者在联合使用阿托伐他汀钙治疗前后(原服用的降压药不变)其血压值的变化情况。数据用t检验分析处理。结果顽固性高血压患者在联用阿托伐他汀钙治疗后血压有所下降,数据经统计学检验存在统计学差异(P<0.05),而患者对阿托伐他汀钙的耐受性均表现良好。结论阿托伐他汀钙对中老年顽固性高血压病能起到协同的降压效果。 Objective To analyze and explore the influence of depresser effect to the unprogressive high blood pres- sure of the Medium - old - age patients through taking Atorvastatin calcium tablets. Methods Choose 86 hospitalization or out - patient pationts at our hospital that already explicit diagnosed unprogressive high blood pressure, after the normal treat- ments by taking some certains hypotensor( using quantum satis of 3 spiecies or above 3 spiecies hypotensors together), that all the patients can not attain to the target BP 140/90 mm Hg by 3 ~6 months. Afterwards, to take Atorvastatin calcium tablets 20 mg, once everyday, which visit for 3 ~ 6 months ( average 4 months). Then observe the variations of resuits that the patients' blood pressure descend before and after using Atorvastatin calcium tablets ( the former hypotensors are constant). The datas is analyzed with the "t" test. Results The unprogressive high blood pressure of the patients' is descensus by using Ator- vastatin calcium tablets. The sample data is diffrence by statistics analysis ( P 〈 0.05 ), however the torlerance of the pationt's showed good expression by taking Atorvastatin calcium tablets. Conclusion To take Atorvastatin calcium tablets can get the synergetic depresser effect with regard to unprogressive high blood pressure of the medium - old - age patiouts.
作者 张绍深
出处 《中国医学创新》 CAS 2011年第19期14-16,共3页 Medical Innovation of China
关键词 中老年人 顽固性高血压 阿托伐他汀钙 降压效果 Medium - old - age patients Unprogressive high blood pressure Atorvastatin calcium tablets de- presser effect
  • 相关文献

参考文献5

二级参考文献13

  • 1COLLINS R,MACMAHON S.Blood pressure,antihypertensive drug treatment and the risks of stroke and of coronary heart disease[J].Br Med Bull,1994,50(1):272-298.
  • 2SEVER P S,DAHLOF B,POULTER N R,et al.Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations,in the Anglo-Scandinavian Cardiac Outcomes Trim-Lipid Lowering Arm(ASCOT-LLA):a multicentre randomized controlled trial[J].Lancet,2003,361(9364):1149-1158.
  • 3中国高血压防治指南(2005修订版)[M].北京:人民卫生出版社,2005.
  • 4MANCIA G,DE BACKER G,DOMINICZAK A,et al.2007guidelines for the management of arterial hypertension:the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension(ESH)and of the European Society of Cardiology(ESC)[J].Eur Heart J,2007,28(12):1462-1536.
  • 5ROSENDORFF C,BLACK H R,CANNON C P,et al.Treatment of hypertension in the prevention and management of ischemic heart disease:a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention[J].Circulation,2007,115(21):2761-2788.
  • 6中国成人血脂异常防治指南(2007)[M].北京:人民卫生出版社,2007.
  • 7PARVING H H,LEHNERT H,BROCHNER-MORTENSEN J,et al.The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes[J].N Engl J Med,2001,345(12):870-878.
  • 8KDOQI.Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease[J].AJKD,2007,49(2 Suppl 2):S13-S154.
  • 9TAZEEN H,PAUL C,CHRISTOPHER H,et al.Progression of chronic kidney disease:the role of blood pressure control,proteinuria,and angiotensin-converting enzyme inhibition:a patient-level meta-analysis[J].Ann Intern Med,2003,139(4):244-252.
  • 10ZEEUW D D,REMUZZI G,PARVING H H,et al.Albuminuria,a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy[J].Circulation,2004,110(8):921-927.

共引文献2621

同被引文献39

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部